Ozempic: A Miracle Drug or the Start of a Public Health Crisis?

(Source)   Ozempic, an injectable diabetes drug manufactured by Novo Nordisk, has recently increased in popularity and has caught the attention of celebrities and the general public alike. Known for its significant weight loss effects, Ozempic and similar products are changing how Americans approach nutrition, exercise, and body image. In addition to these potentially dangerous

Running Out of Beds: How COVID-19 Demonstrates the Need to Repeal State Certificate of Need Laws

(Source) During the onset of the COVID-19 pandemic in the United States, states struggled in part because the disease caused demand for hospital beds to outstrip supply. Around one month into the pandemic, in New York City, for example, only about 300 intensive care unit (“ICU”) beds remained available. States reacted by creating more medical

Healthcare Price Transparency in a Privately Insured United States: Is Patient Ignorance Bliss?

(Source) It is no secret that the United States is the only industrialized nation without a single-payer universal healthcare program. Among the many issues created by the high cost of healthcare, both parties agree that unexpected, and often extremely expensive, medical bills present a serious threat to financial security in a nation where around two-thirds

The Pacemaker Tax

Zach Zemlin looks at the medical device tax in the Affordable Care Act and how the new tax may affect the American medical device industry.

The Rising Cost of Cheaper Prescription Drugs

Zach Zemlin looks at the role played by copay cards in our nation’s rising healthcare costs.